NCT07378462

Brief Summary

Temporomandibular disorders (TMDs) are the most common cause of non-dental orofacial pain, involving the temporomandibular joint (TMJ), masticatory muscles, or associated structures. Globally, TMD is the second most prevalent musculoskeletal pain condition after low back pain. Epidemiological data show a high prevalence of TMD symptoms, particularly among women and Asian populations, with significant disease burden reported in Nepal. Conservative management remains the mainstay of TMD treatment, as evidence supporting surgical intervention is limited and inconclusive. Among conservative modalities, physical therapies such as ultrasound therapy and low-level laser therapy (LLLT) have gained attention for pain reduction and functional improvement. Ultrasound therapy produces thermal and non-thermal effects that enhance blood flow, reduce muscle spasm, improve tissue extensibility, and promote healing. LLLT, through photobiomodulation, acts at the cellular level by increasing ATP production, reducing inflammatory mediators, enhancing collagen synthesis, and providing analgesic and anti-inflammatory effects. Although several international studies have evaluated ultrasound and LLLT individually or in combination, limited studies have directly compared their effectiveness in TMD, and no such studies have been conducted in Nepal. Therefore, this study aims to compare the effectiveness of therapeutic ultrasound and LLLT in reducing pain and improving mouth opening in patients with TMD presenting to BPKIHS. This was a retrospective randomized controlled study conducted at the Department of Oral Medicine and Radiology, College of Dental Surgery, BPKIHS. A total of 46 patients diagnosed with myalgia of masticatory muscles and/or TMJ arthralgia according to DC/TMD criteria were included using purposive sampling. Patients were allocated into two groups: Group A received low-level laser therapy (650 nm wavelength, 2 J/cm² for 3 minutes) and Group B received therapeutic ultrasound (1 MHz, 1.3 W/cm², continuous mode for 5 minutes). Five treatment sessions had been administered over two weeks. Pain intensity was assessed using the Visual Analogue Scale (VAS) at each visit, while inter-incisal mouth opening was measured using a metallic scale at baseline and at the final visit. Primary outcome measure was the difference in VAS scores in patients undergoing ultrasound therapy and low-level laser therapy for temporomandibular disorder before and after therapy. Secondary outcome measures included the difference in inter-incisal mouth opening before and after therapy and the effectiveness of ultrasound therapy and low-level laser therapy in reducing pain in patients with arthralgia and myalgia. Data were analyzed using SPSS version 11.5. Descriptive statistics were calculated, and inferential tests including independent and paired t-tests (or non-parametric equivalents), ANOVA/Kruskal-Wallis tests, and logistic regression were applied where appropriate. Ethical clearance was obtained from the Institutional Review Committee, BPKIHS with Ref. 20/080/081-IRC, Code no. IRC/2509/023.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 21, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 17, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2024

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

January 18, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 30, 2026

Completed
Last Updated

January 30, 2026

Status Verified

January 1, 2026

Enrollment Period

10 months

First QC Date

January 18, 2026

Last Update Submit

January 27, 2026

Conditions

Keywords

low-level laser therapyTemporomandibular Disorder (TMD)ultrasound therapy

Outcome Measures

Primary Outcomes (1)

  • Compare the difference in mean pain intensity scores in patients undergoing Low-Level Laser Therapy and Ultrasound Therapy for Temporomandibular Disorder before and after therapy.

    Description: Pain intensity was assessed using the Visual Analogue Scale (VAS). The VAS consisted of a 10-cm horizontal line, with the left end representing "no pain" (0) and the right end representing "worst imaginable pain" (10). Higher scores indicated greater pain intensity. Participants were instructed on the use of the scale and were asked to mark a single point on the line corresponding to their current level of temporomandibular joint pain. Pain scores were recorded at baseline (pre-therapy) and at subsequent visits during the treatment period. The change in pain intensity was calculated by comparing pre- and post-therapy scores and was expressed as percentage reduction in VAS score.

    From enrollment to the end of treatment at 2 weeks

Secondary Outcomes (2)

  • Compare the difference in mean inter-incisal mouth opening in patients undergoing Low-Level Laser Therapy and Ultrasound Therapy for Temporomandibular Disorder pre- and post-therapy

    From enrollment to the end of treatment at 2 weeks

  • Compare the effectiveness of Low-Level Laser Therapy and Ultrasound Therapy in reducing pain in patients with temporomandibular joint arthralgia and myalgia of the masseter and temporalis muscles.

    From enrollment to the end of treatment at 2 weeks

Study Arms (2)

Low-level laser therapy

EXPERIMENTAL

Participants in this arm received low-level laser therapy applied to the area of maximum pain in the temporomandibular region. The therapy was delivered using a single-probe laser emitting infrared radiation at a wavelength of 650 nm, with an energy density of 2 J/cm² and an output power of 80 mW for 3 minutes per session. Treatment was administered over five sessions.

Device: Low-Level Laser Therapy

Ultrasound therapy

EXPERIMENTAL

Participants in this arm received therapeutic ultrasound applied to the affected temporomandibular region. Ultrasound was delivered at a frequency of 1 MHz and an intensity of 1.3 W/cm² in continuous mode for 5 minutes per side per session. Treatment was administered over five sessions.

Device: Ultrasound therapy

Interventions

Low-level laser therapy delivered using a single-probe laser emitting infrared radiation at 650 nm, with an energy density of 2 J/cm² and output power of 80 mW for 3 minutes per session, applied to the area of maximum pain.

Also known as: Light Therapy, Low-Level, Photobiomodulation Therapy
Low-level laser therapy

Therapeutic ultrasound delivered at a frequency of 1 MHz and intensity of 1.3 W/cm² in continuous mode for 5 minutes per side per session, applied to the affected temporomandibular region.

Also known as: Therapeutic ultrasound
Ultrasound therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Patient diagnosed with myalgia of masseter and temporalis muscles and arthralgia of TMJ based on Diagnostic Criteria for Temporomandibular Disorders DC/TMD.

You may not qualify if:

  • Patients who were not willing to participate in the research.
  • Patients who were undergoing treatment or had already undergone treatment for temporomandibular disorders within the preceding three months.
  • Patients who were taking antidepressants, analgesics, or antipsychotic medications.
  • Patients who had structural bony abnormalities of the temporomandibular joint on radiographic examination.
  • Patients with the presence of joint disorders.
  • Pregnant women.
  • Patients with a history of facial trauma or fractures of the facial bones.
  • Patients who presented with severe pain.
  • Patients with severely reduced mouth opening (i.e., less than 10 mm).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

B.P. Koirala Institute of Health Sciences

Dharān, Koshi, 56700, Nepal

Location

Related Publications (27)

  • Ramachandra, Vijayalakshmi & Mubeen, & Rajguru, Preeti. (2015). Phonophoresis in temporomandibular joint disorders: A clinical trial. Journal of Advanced Clinical & Research Insights. 2. 259-264. 10.15713/ins.jcri.90.

    BACKGROUND
  • Rai S, Ranjan V, Misra D, Panjwani S. Management of myofascial pain by therapeutic ultrasound and transcutaneous electrical nerve stimulation: A comparative study. Eur J Dent. 2016 Jan-Mar;10(1):46-53. doi: 10.4103/1305-7456.175680.

    PMID: 27011739BACKGROUND
  • Cavalcanti MF, Silva UH, Leal-Junior EC, Lopes-Martins RA, Marcos RL, Pallotta RC, Diomede F, Trubiani O, De Isla N, Frigo L. Comparative Study of the Physiotherapeutic and Drug Protocol and Low-Level Laser Irradiation in the Treatment of Pain Associated with Temporomandibular Dysfunction. Photomed Laser Surg. 2016 Dec;34(12):652-656. doi: 10.1089/pho.2016.4195. Epub 2016 Nov 29.

    PMID: 27898256BACKGROUND
  • Ren H, Liu J, Liu Y, Yu C, Bao G, Kang H. Comparative effectiveness of low-level laser therapy with different wavelengths and transcutaneous electric nerve stimulation in the treatment of pain caused by temporomandibular disorders: A systematic review and network meta-analysis. J Oral Rehabil. 2022 Feb;49(2):138-149. doi: 10.1111/joor.13230. Epub 2021 Aug 21.

    PMID: 34289157BACKGROUND
  • Ahmad, Rehab & Mohamed Abd Elatief, Emad & Sayed, Wadida & Ali, Rania & Ashour, Essam & Abdelsamee, Mohamed. (2018). Effect of Conventional Therapy and Low-Level Laser Therapy on Pain and Limitations of Daily Functions in Patients with Temporomandibular Joint Dysfunction. International Journal of Physiotherapy and Research. 6. 2797-2805. 10.16965/ijpr.2018.154.

    BACKGROUND
  • Elgohary HM, Eladl HM, Soliman AH, Soliman ES. Effects of Ultrasound, Laser and Exercises on Temporomandibular Joint Pain and Trismus Following Head and Neck Cancer. Ann Rehabil Med. 2018 Dec;42(6):846-853. doi: 10.5535/arm.2018.42.6.846. Epub 2018 Dec 28.

    PMID: 30613078BACKGROUND
  • Panhóca, Vitor Hugo et al. "Increased Oral Health-Related Quality of Life Postsynergistic Treatment with Ultrasound and Photobiomodulation Therapy in Patients with Temporomandibular Disorders." Photobiomodulation, photomedicine, and laser surgery vol. 37, 11 (2019): 694-699. doi:10.1089/photob.2019.4697

    BACKGROUND
  • Khairnar, Sanyukta et al. "Comparative evaluation of low-level laser therapy and ultrasound heat therapy in reducing temporomandibular joint disorder pain." Journal of dental anesthesia and pain medicine vol. 19,5 (2019): 289-294.

    BACKGROUND
  • Lin YS, Huang MH, Chai CY. Effects of helium-neon laser on the mucopolysaccharide induction in experimental osteoarthritic cartilage. Osteoarthritis Cartilage. 2006 Apr;14(4):377-83. doi: 10.1016/j.joca.2005.10.010. Epub 2005 Dec 13.

    PMID: 16359876BACKGROUND
  • Lin YS, Huang MH, Chai CY, Yang RC. Effects of helium-neon laser on levels of stress protein and arthritic histopathology in experimental osteoarthritis. Am J Phys Med Rehabil. 2004 Oct;83(10):758-65. doi: 10.1097/01.phm.0000137310.15943.19.

    PMID: 15385784BACKGROUND
  • Carvalho CM, Lacerda JA, dos Santos Neto FP, de Castro IC, Ramos TA, de Lima FO, de Cerqueira Luz JG, Ramalho MJ, dos Santos JN, Pinheiro AL. Evaluation of laser phototherapy in the inflammatory process of the rat's TMJ induced by carrageenan. Photomed Laser Surg. 2011 Apr;29(4):245-54. doi: 10.1089/pho.2009.2685.

    PMID: 21457090BACKGROUND
  • Sakurai Y, Yamaguchi M, Abiko Y. Inhibitory effect of low-level laser irradiation on LPS-stimulated prostaglandin E2 production and cyclooxygenase-2 in human gingival fibroblasts. Eur J Oral Sci. 2000 Feb;108(1):29-34. doi: 10.1034/j.1600-0722.2000.00783.x.

    PMID: 10706474BACKGROUND
  • Bjordal JM, Couppe C, Chow RT, Tuner J, Ljunggren EA. A systematic review of low level laser therapy with location-specific doses for pain from chronic joint disorders. Aust J Physiother. 2003;49(2):107-16. doi: 10.1016/s0004-9514(14)60127-6.

    PMID: 12775206BACKGROUND
  • Skinner SM, Gage JP, Wilce PA, Shaw RM. A preliminary study of the effects of laser radiation on collagen metabolism in cell culture. Aust Dent J. 1996 Jun;41(3):188-92. doi: 10.1111/j.1834-7819.1996.tb04854.x.

    PMID: 8768644BACKGROUND
  • Chen, J et al. "Efficacy of low-level laser therapy in the treatment of TMDs: a meta-analysis of 14 randomised controlled trials." Journal of oral rehabilitation vol. 42,4 (2015): 291-9. doi:10.1111/joor.12258

    BACKGROUND
  • Allen LV, Popovich NG, Ansel HC. Ansel's pharmaceutical dosage forms and drug delivery systems. Transdermal Drug Delivery Systems. 8th ed. India: Gopsons Papers Ltd.; 2006. p. 298 315.

    BACKGROUND
  • Baker KG, Robertson VJ, Duck FA. A review of therapeutic ultrasound: biophysical effects. Phys Ther. 2001 Jul;81(7):1351-8.

    PMID: 11444998BACKGROUND
  • 10. Szabo, T. L. (2004). ULTRASOUND-INDUCED BIOEFFECTS. Diagnostic Ultrasound Imaging, 489-516. doi:10.1016/b978-012680145-3/50016-5

    BACKGROUND
  • Draper DO. Facts and misfits in ultrasound therapy: steps to improve your treatment outcomes. Eur J Phys Rehabil Med. 2014 Apr;50(2):209-16. Epub 2014 Mar 5.

    PMID: 24594854BACKGROUND
  • Shukla D, Muthusekhar MR. Efficacy of low-level laser therapy in temporomandibular disorders: A systematic review. Natl J Maxillofac Surg. 2016 Jan-Jun;7(1):62-66. doi: 10.4103/0975-5950.196127.

    PMID: 28163481BACKGROUND
  • Rahimi A, Rabiei S, Mojahedi SM, Kosarieh E. Application of low level laser in temporomandibular disorders. J Lasers Med Sci 2011; 2: 165-70.

    BACKGROUND
  • Shivhare P, Singh V, Giri R, Singh A, Penumatcha MR, Taparia N, Sabah N. Prevalence of temporomandibular disorders among Nepalese population. Journal of Chitwan Medical College. 2019; 9(29):34-42

    BACKGROUND
  • Lei J, Fu J, Yap AU, Fu KY. Temporomandibular disorders symptoms in Asian adolescents and their association with sleep quality and psychological distress. Cranio. 2016 Jul;34(4):242-9. doi: 10.1179/2151090315Y.0000000021. Epub 2016 Apr 28.

    PMID: 27125298BACKGROUND
  • Von Korff M, Dworkin SF, Le Resche L, Kruger A. An epidemiologic comparison of pain complaints. Pain. 1988 Feb;32(2):173-183. doi: 10.1016/0304-3959(88)90066-8.

    PMID: 3362555BACKGROUND
  • Scrivani SJ, Keith DA, Kaban LB. Temporomandibular disorders. N Engl J Med. 2008 Dec 18;359(25):2693-705. doi: 10.1056/NEJMra0802472. No abstract available.

    PMID: 19092154BACKGROUND
  • Mazzetto MO, Carrasco TG, Bidinelo EF, de Andrade Pizzo RC, Mazzetto RG. Low intensity laser application in temporomandibular disorders: a phase I double-blind study. Cranio. 2007 Jul;25(3):186-92. doi: 10.1179/crn.2007.029.

    PMID: 17696035BACKGROUND
  • Carrasco TG, Mazzetto MO, Mazzetto RG, Mestriner W Jr. Low intensity laser therapy in temporomandibular disorder: a phase II double-blind study. Cranio. 2008 Oct;26(4):274-81. doi: 10.1179/crn.2008.037.

    PMID: 19004308BACKGROUND

MeSH Terms

Conditions

Temporomandibular Joint Disorders

Interventions

Low-Level Light TherapyUltrasonic Therapy

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsPhototherapyDiathermyHyperthermia, Induced

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: An interventional, comparative, parallel-group clinical study conducted in patients diagnosed with temporomandibular disorders according to DC/TMD criteria. Participants were allocated into two groups to receive either Low-Level Laser Therapy or Therapeutic Ultrasound Therapy, and outcomes were assessed over five treatment sessions.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Resident

Study Record Dates

First Submitted

January 18, 2026

First Posted

January 30, 2026

Study Start

July 21, 2023

Primary Completion

May 17, 2024

Study Completion

November 20, 2024

Last Updated

January 30, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

All Individual participant data (IPD) collected throughout the trial will be made available upon reasonable request. De-identified data from the 46 study participants will be shared with other researchers for academic and research purposes, subject to ethical approval and compliance with institutional policies and participant confidentiality.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
All the data are collected and will be provided when and where required.

Locations